Page last updated: 2024-10-27

berotek and Bone Loss, Osteoclastic

berotek has been researched along with Bone Loss, Osteoclastic in 1 studies

Fenoterol: A synthetic adrenergic beta-2 agonist that is used as a bronchodilator and tocolytic.
fenoterol : A member of the class resorcinols that is 5-(1-hydroxyethyl)benzene-1,3-diol in which one of the methyl hydrogens is replaced by a 1-(4-hydroxyphenyl)propan-2-amino group. A beta2-adrenergic agonist, it is used (as the hydrobromide salt) as a bronchodilator in the management of reversible airway obstruction.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Śliwiński, L1
Cegieła, U1
Pytlik, M1
Folwarczna, J1
Janas, A1
Zbrojkiewicz, M1

Other Studies

1 other study available for berotek and Bone Loss, Osteoclastic

ArticleYear
Effects of fenoterol on the skeletal system depend on the androgen level.
    Pharmacological reports : PR, 2017, Volume: 69, Issue:2

    Topics: Androgens; Animals; Bone and Bones; Bone Resorption; Fenoterol; Male; Mice; Mice, Inbred BALB C; Orc

2017